Eastern cooperative oncology group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment

Journal of Clinical Oncology

Volumn 16, Issue 5, 1998, Pages 1669-1676

  Falkson, Geoffrey ^a   Gelman, Rebecca S ^a   Pandya, Kishan J ^a   Osborne, Kent C ^a   Tormey, Douglass ^a   Cummings, Frank J ^a   Sledge, George W ^a   Abeloff, Martin D ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; FLUOXYMESTERONE; METHOTREXATE; PREDNISONE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER REGRESSION; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL OBSERVATION; DIABETES MELLITUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; METASTASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0031859604     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.5.1669     Document Type: Article

References (16)

1. Falkson G, Gelman R, Falkson CI, et al.: Factors predicting for response, time to treatment failure, and survival in women with metastatic cancer treated with DAVTH: A prospective Eastern Cooperative Oncology Group study. J Clin Oncol 9:2153-2161,1991
2. Falkson G, Gelman RS, Click J, et al.: Metastatic breast cancer: Higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study. Ann Oncol 3:768-770,1992
3. Pandya KJ, Neuberg D, Falkson G, et al.: A preliminary report of induction chemotherapy for hormone independent or hormone refractory metastatic breast carcinoma. An Intergroup study. Proc Am Soc Clin Oncol 14:111,1995 (abstr 143)
4. Sledge GW, Neuberg D, Falkson G, et al.: Chemotherapy vs chemo-hormonal therapy as initial therapy for ER+/unknown metastatic breast cancer: E3168 Proc Am Soc Clin Oncol 14:105,1995(abstr 121)
5. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. JAMA53:457-481,1958
6. Peto R, Peto J: Asymptomatically efficient rank invariant test procedures. J R Stat Soc A 135:185-198,1971
7. Bernstein D, Lagakos SW: Sample size and power determination for stratified clinical trials. J Stat Comput Simul 8:65-73,1978
8. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220,1972
9. Muss HB, Case LD, Richards F H, et al.: Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association. N Engl J Med 325:1342-1348,1991
10. Peters WP, Jones RB, Vredenburgh J, et'al: A large, prospective, randomized trial of high-dose combination alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM). Proc Am Soc ClinOncol 15:121,1996(abstr 149)
11. Falkson G, Gelman R, Click J, et al.: Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 12:45-49, 1994
12. Coates A, Gebski V, Signorini D, et al.: Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 10:1833-1838,1992
13. Harris AL, Cantwell BMJ, Carmichael J, et al.: Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer. Lancet 335:186-190,1990
14. Cocconi G, Bisagni G, Bacchi M, et al.: A comparison of continuation versus late intensification followed by discontinuation of chemotherapy in advanced breast cancer. A prospective randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). Ann Oncol 1:36-4,1990
15. Greenberg PAC, Hortobagyi GN, Smith TL, et al.: Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14:2197-2205, 1996
16. Falkson G, Holcroft C, Gelman RS, et al.: Ten-year follow-up study of premenopausal women with metastatic breast cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 13:1453-1458,1995